Lorenil*1cps Molli Vag 600mg

NAME
LORENIL SOFT VAGINAL CAPSULES

PHARMACOTHERAPEUTIC CATEGORY
Antimicrobials and antiseptics, excluding associations with corticosteroids.

ACTIVE PRINCIPLES
Fenticonazole nitrate.

EXCIPIENTS
Soft vaginal capsules 200 mg: triglycerides of saturated fatty acids; anhydrous colloidal silica. Constituents of the shell: gelatin; glycerol; titanium dioxide; sodium ethyl hydroxybenzoate; sodium propylhydroxybenzoate. Soft vaginal capsules 600 mg: liquid paraffin; white petroleum jelly; soy lecithin; jelly; glycerol; titanium dioxide; sodium ethyl hydroxybenzoate; sodium propylhydroxybenzoate.

INDICATIONS
Candidiasis of the genital mucous membranes (vulvovaginitis, affected, infectious fluor).

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.

DOSAGE
Soft vaginal capsules: 1 soft vaginal capsule of 200 mg in the evening before bedtime for 3 days or according to the judgment of the doctor. 1 vaginal soft capsule of 600 mg in the evening in single administration. In case of persistence of the symptoms, a second administration can be repeated after three days. The soft capsules are introduced deeply into the vagina up to the level of the fornixes.

STORAGE
Do not store above 30 degrees C.

WARNINGS
The use, especially if prolonged, of products for topical use, can give rise to sensitization phenomena. At the time of intravaginal introduction, a modest burning sensation may be found which disappears rapidly.

INTERACTIONS
Not known.

SIDE EFFECTS
The medicine is generally well tolerated on the mucous membranes; only exceptionally mild and transient erythematous reactions have been reported. In case of hypersensitivity reactions or the development of resistant microorganisms, treatment must be stopped. The drug, in the recommended conditions of use, is only poorly absorbed, so systemic repercussions can be excluded.

PREGNANCY AND BREASTFEEDING
Although the absorption of the drug is poor, the use of the product during pregnancy and lactation is not recommended except in special cases and after a careful evaluation of the benefit / risk ratio.